We induced lung adenocarcinomas in a KRasLSLG12Vge/+o;P53LoxP/LoxP mouse model by intranasal administration of adeno‐Cre, causing an activation mutation of Kras in parallel with Tp53 inactivation. This evidence concerns the gene KRAS and lung adenocarcinoma.